The Smart Investor
    Facebook Instagram
    Saturday, October 3
    Facebook Instagram LinkedIn
    The Smart Investor
    • Home
    • About
      • About Us
      • Careers
    • Smart Investing
      • Getting Started
      • Investing Strategy
      • Smart Analysis
      • Smart Reads
    • US Stocks
    • Special Free Reports!
    • As Featured on BT
    • Our Services
      • Our Services
      • Subscribe now!
    • Login
    • Cart
    The Smart Investor
    Home»Dividend Stocks»Top Stock Highlights of the Week: CICT and FCT Bid for Mercatus, Parkway Life REIT and SBS Transit
    Dividend Stocks

    Top Stock Highlights of the Week: CICT and FCT Bid for Mercatus, Parkway Life REIT and SBS Transit

    We look at the contenders for Mercatus’ retail asset portfolio and review the earnings from a healthcare REIT and a public transport operator.
    Royston Y.By Royston Y.August 13, 2022Updated:September 14, 20225 Mins Read
    Facebook Twitter LinkedIn Email WhatsApp
    Share
    Facebook Twitter LinkedIn Email WhatsApp

    Welcome to this week’s edition of top stock highlights where we feature interesting business snippets from earnings announcements and news reports.

    Bids for Mercatus’ retail portfolio

    It was just around two months ago when we wrote about Mercatus Co-operative, a unit of NTUC, offering a bunch of its retail properties for sale.

    The estimated valuation for this portfolio is above S$4 billion.

    Back then, we speculated that several retail REITs in Singapore may be interested contenders for these assets as they include popular suburban malls such as Jurong Point and a 50% stake in Nex mall.

    Now, the names of some of the contenders have been revealed, and we were spot on.

    The reported contenders include CapitaLand Integrated Commercial Trust (SGX: C38U), or CICT, Hong Kong-listed Link REIT (HKSE: 0823), Frasers Centrepoint Trust (SGX: J69U), or FCT, and Lendlease Global Commercial REIT (SGX: JYEU), or LREIT.

    The size of the portfolio, however, means that the winning bidder should have both financial heft and access to capital.

    A strong sponsor could provide the REIT with both.

    CICT’s sponsor is property giant CapitaLand Investment Limited (SGX: 9CI), FCT has Frasers Property Limited (SGX: TQ5) as its sponsor, and LREIT has Australia-listed property company Lendlease Group (ASX: LLC) as its sponsor.

    However, it remains to be seen if any of the REITs can digest such a large acquisition without taking on significant debt or resorting to an equity fundraising exercise.

    CICT’s aggregate leverage has exceeded 40%, clocking in at 40.6% as of 30 June 2022.

    The retail cum commercial REIT may need to tap on capital markets to consummate a deal to prevent its gearing level from breaching the 50% threshold.

    LREIT’s gearing is also at the 40% level, but its manager has indicated that it is out of the running for these properties.

    FCT has lower aggregate leverage at 33.9% and Mercatus’ assets will also complement its portfolio of suburban malls.

    The outcome of these bids will be closely watched and it’s anyone’s guess if either of these REITs or another unnamed contender may snag these valuable malls.

    Parkway Life REIT (SGX: C2PU)

    Parkway Life REIT has extended its unbroken track record of consecutive increases in distribution per unit (DPU).

    The healthcare REIT has announced a respectable set of earnings for its fiscal 2022’s first half (1H2022).

    Gross revenue inched up 1% year on year to S$60.2 million, contributed by the acquisitions of three nursing homes in Japan last year as well as higher rent from its Singapore hospitals.

    Net property income increased by 1.1% year on year to S$56 million as property expenses increased by just 0.7% year on year.

    DPU improved by 1.5% year on year to S$0.0706, taking annualised DPU to S$0.1412.

    Assuming Parkway Life REIT can keep up this momentum, FY2022’s DPU will be marginally higher than FY2021’s DPU of S$0.1408.

    The healthcare REIT’s gearing stood at 32.5% as of 30 June 2022, giving the REIT a debt headroom of close to S$790 million before hitting the 50% threshold.

    Debt metrics look healthy with a very low cost of debt of 0.61% and a high-interest cover ratio of 19.8 times.

    Close to 82% of the REIT’s borrowings are hedged, thus protecting it from sharp rises in interest rates.

    SBS Transit Limited (SGX: S61)

    SBS Transit, or SBST, also reported its 1H2022 results this week.

    Revenue rose 14.3% year on year to S$732.4 million as public transport ridership improved with the opening up of Singapore’s economy and all workers being allowed to return to their offices.

    Operating profit improved by 12.6% year on year to S$43 million.

    However, if the COVID-19 government relief amount of S$34.6 million was adjusted from 1H2021’s results, then SBST’s operating profit would have soared from S$3.6 million a year ago to S$43 million in 1H2022.

    Net profit dipped by 5% year on year due to a significantly higher tax expense for the group.

    SBST saw average daily ridership for the North East MRT line increase by 14.6% year on year to 445,000 trips, while its Downtown MRT line saw ridership jump by 17.4% year on year to 327,000 trips.

    The group warns that revenue from the bus business will be lower from 1 September as the extension of five negotiated bus packages is based on lower service fees.

    Coupled with higher wage costs and elevated fuel prices, SBST expects pressure on its bottom line.

    The group has declared an interim dividend of S$0.0545, slightly lower than the S$0.0575 paid out a year ago.

    Looking for investment opportunities in 2022 and beyond? In our latest special FREE report “Top 9 Dividend Stocks for 2022”, we’re revealing 3 groups of stocks that are set to deliver mouth-watering dividends in the coming year. 

    Our safe-harbour stocks are a set of blue-chip companies that have been able to hold their own and deliver steady dividends. Growth accelerators stocks are enterprising businesses poised to continue their growth.  And finally, the pandemic surprises are the unexpected winners of the pandemic. 

    Want to know more? Click HERE to download for free now!  

    Follow us on Facebook and Telegram for the latest investing news and analyses!

    Disclaimer: Royston Yang does not own shares in any of the companies mentioned.

    Yahoo
    Share. Facebook Twitter LinkedIn Email WhatsApp

    Related Posts

    Top Stock Market Highlights of the Week: City Developments, Stoneweg Europe Stapled Trust, MAS, DFI Retail and Anthropic

    October 3, 2026
    Smart Thought Of The Week

    Smart Thought Of The Week: Reality

    October 2, 2026
    Bargain or trap?

    Bargain or Trap? 3 Worst-Performing SGX Blue Chips in Q3 2026

    October 2, 2026
    Facebook Instagram LinkedIn Telegram YouTube TikTok
    • Careers
    • Disclaimer & Privacy Policy
    • Advertising & Media Enquiries
    • Subscription Terms of Service
    © 2026 The Smart Investor. All Rights Reserved. The Smart Investor, thesmartinvestor.com.sg, an investment education website managed by The Investing Hustle Pte Ltd (Company Reg No. 201933459Z) is not licensed or otherwise regulated by the Monetary Authority of Singapore, and in particular, is not licensed or regulated to carry on business in providing any financial advisory service. Accordingly, any information provided on this site is meant purely for informational and investor educational purposes and should not be relied upon as financial advice. No information is presented with the intention to induce any reader to buy, sell, or hold a particular investment product or class of investment products. Rather, the information is presented for the purpose and intentions of educating readers on matters relating to financial literacy and investor education. Accordingly, any statement of opinion on this site is wholly generic and not tailored to take into account the personal needs and unique circumstances of any reader. The Smart Investor does not recommend any particular course of action in relation to any investment product or class of investment products. Readers are encouraged to exercise their own judgment and have regard to their own personal needs and circumstances before making any investment decision, and not rely on any statement of opinion that may be found on this site.

    Type above and press Enter to search. Press Esc to cancel.